• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体内的氧化三甲胺(TMAO)与健康

Trimethylamine N-oxide (TMAO) in human health.

作者信息

Gatarek Paulina, Kaluzna-Czaplinska Joanna

机构信息

Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Lodz, Poland.

出版信息

EXCLI J. 2021 Feb 11;20:301-319. doi: 10.17179/excli2020-3239. eCollection 2021.

DOI:10.17179/excli2020-3239
PMID:33746664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7975634/
Abstract

Due to numerous links between trimethylamine-N-oxide (TMAO) and various disorders and diseases, this topic is very popular and is often taken up by researchers. TMAO is a low molecular weight compound that belongs to the class of amine oxides. It is formed by the process of oxidation of trimethylamine (TMA) by the hepatic flavin monooxygenases (FMO1 and FMO3). TMAO is mainly formed from nutritional substrates from the metabolism of phosphatidylcholine/choline, carnitine, betaine, dimethylglycine, and ergothioneine by intestinal microflora in the colon. Its level is determined by many factors, such as age, gender, diet, intestinal microflora composition, kidney function, and also liver flavin monooxygenase activity. Many studies report a positive relationship between the level of TMAO concentration and the development of various diseases, such as cardiovascular diseases and cardiorenal disorders, including atherosclerosis, hypertension, ischemic stroke, atrial fibrillation, heart failure, acute myocardial infarction, and chronic kidney disease, and also diabetes mellitus, metabolic syndrome, cancers (stomach, colon), as well as neurological disorders. In this review, we have summarized the current knowledge on the effects of TMAO on human health, the relationship between TMAO and intestinal microbiota, the role of TMAO in different diseases, and current analytical techniques used in TMAO determination in body fluids.

摘要

由于氧化三甲胺(TMAO)与多种病症和疾病之间存在众多联系,该主题非常热门,经常被研究人员探讨。TMAO是一种低分子量化合物,属于氧化胺类。它是由肝脏黄素单加氧酶(FMO1和FMO3)将三甲胺(TMA)氧化而成。TMAO主要由结肠中肠道微生物群对磷脂酰胆碱/胆碱、肉碱、甜菜碱、二甲基甘氨酸和麦角硫因代谢产生的营养底物形成。其水平由许多因素决定,如年龄、性别、饮食、肠道微生物群组成、肾功能以及肝脏黄素单加氧酶活性。许多研究报告了TMAO浓度水平与各种疾病的发生发展之间存在正相关,如心血管疾病和心肾疾病,包括动脉粥样硬化、高血压、缺血性中风、心房颤动、心力衰竭、急性心肌梗死和慢性肾病,还有糖尿病、代谢综合征、癌症(胃癌、结肠癌)以及神经疾病。在本综述中,我们总结了关于TMAO对人体健康影响的现有知识、TMAO与肠道微生物群的关系、TMAO在不同疾病中的作用以及目前用于测定体液中TMAO的分析技术。

相似文献

1
Trimethylamine N-oxide (TMAO) in human health.人体内的氧化三甲胺(TMAO)与健康
EXCLI J. 2021 Feb 11;20:301-319. doi: 10.17179/excli2020-3239. eCollection 2021.
2
Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.膳食酚类及其微生物代谢物对肝黄素单加氧酶 3 氧化三甲胺生成三甲胺 N-氧化物的抑制作用较弱。
J Nutr Biochem. 2023 Oct;120:109428. doi: 10.1016/j.jnutbio.2023.109428. Epub 2023 Aug 5.
3
Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?饮食可以调节三甲胺 N-氧化物(TMAO)的产生吗?目前我们了解多少?
Eur J Nutr. 2021 Oct;60(7):3567-3584. doi: 10.1007/s00394-021-02491-6. Epub 2021 Feb 3.
4
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.黄素单加氧酶 3 是机体三甲基胺 N-氧化物生成途径中的主要肝酶,可调节血小板反应性和血栓形成风险。
J Thromb Haemost. 2018 Sep;16(9):1857-1872. doi: 10.1111/jth.14234. Epub 2018 Aug 9.
5
Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.氧化三甲胺、微生物群与心脏和肾脏疾病
Annu Rev Nutr. 2017 Aug 21;37:157-181. doi: 10.1146/annurev-nutr-071816-064732. Epub 2017 Jul 17.
6
Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.通过改变左旋肉碱的微生物降解来抑制肠道微生物群依赖的促动脉粥样硬化三甲胺 N-氧化物的产生。
Life Sci. 2014 Nov 11;117(2):84-92. doi: 10.1016/j.lfs.2014.09.028. Epub 2014 Oct 7.
7
From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge.从心力衰竭和肾功能不全到心肾综合征:氧化三甲胺可能是一座桥梁。
Front Pharmacol. 2023 Nov 21;14:1291922. doi: 10.3389/fphar.2023.1291922. eCollection 2023.
8
Trimethylamine N-Oxide as a Potential Biomarker for Cardiovascular Disease: Its Association with Dietary Sources of Trimethylamine N-Oxide and Microbiota.氧化三甲胺作为心血管疾病的潜在生物标志物:其与氧化三甲胺饮食来源及微生物群的关联
Eurasian J Med. 2023 Oct;55(1):S21-S26. doi: 10.5152/eurasianjmed.2023.23070.
9
Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.含黄素单加氧酶和氧化三甲胺的变化可能参与肠道微生物群代谢产物三甲胺对非酒精性脂肪性肝病的促进作用。
Biochem Biophys Res Commun. 2022 Feb 26;594:1-7. doi: 10.1016/j.bbrc.2022.01.060. Epub 2022 Jan 16.
10
The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders.肠道微生物衍生代谢物三甲胺 N-氧化物(TMAO)在神经退行性疾病中的作用。
Mol Neurobiol. 2022 Nov;59(11):6684-6700. doi: 10.1007/s12035-022-02990-5. Epub 2022 Aug 20.

引用本文的文献

1
Metabolomic Profiling of Hepatitis B-Associated Liver Disease Progression: Chronic Hepatitis B, Cirrhosis, and Hepatocellular Carcinoma.乙型肝炎相关肝病进展的代谢组学分析:慢性乙型肝炎、肝硬化和肝细胞癌
Metabolites. 2025 Jul 29;15(8):504. doi: 10.3390/metabo15080504.
2
Gut microbiota regulate atherosclerosis via the gut-vascular axis: a scoping review of mechanisms and therapeutic interventions.肠道微生物群通过肠-血管轴调节动脉粥样硬化:机制与治疗干预的范围综述
Front Microbiol. 2025 Aug 8;16:1606309. doi: 10.3389/fmicb.2025.1606309. eCollection 2025.
3
study on prebiotic & choline combination to modulate gut bacteria, enhance choline bioavailability, and reduce TMA production.

本文引用的文献

1
Assessment of trimethylamine-N-oxide at the blood-cerebrospinal fluid barrier: Results from 290 lumbar punctures.血液-脑脊液屏障中氧化三甲胺的评估:290例腰椎穿刺结果
EXCLI J. 2020 Sep 9;19:1275-1281. doi: 10.17179/excli2020-2763. eCollection 2020.
2
Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota.维生素 D 通过调节肠道微生物群降低小鼠血浆三甲胺 N-氧化物水平。
Biomed Res Int. 2020 Oct 5;2020:9896743. doi: 10.1155/2020/9896743. eCollection 2020.
3
Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease.
关于益生元与胆碱组合调节肠道细菌、提高胆碱生物利用度并减少三甲胺生成的研究。
Microbiome Res Rep. 2025 May 7;4(2):21. doi: 10.20517/mrr.2024.90. eCollection 2025.
4
TMAO Activates the NLRP3 Inflammasome, Disrupts Gut-Kidney Interaction, and Promotes Intestinal Inflammation.氧化三甲胺激活NLRP3炎性小体,破坏肠-肾相互作用,并促进肠道炎症。
Int J Mol Sci. 2025 Aug 1;26(15):7441. doi: 10.3390/ijms26157441.
5
Evaluation of prothymosin alpha, trimethylamine-N-oxide, and ischemia-modified albumin in type 2 diabetes mellitus patients with dysregulated lipid profile.对脂质谱紊乱的2型糖尿病患者中前胸腺素α、氧化三甲胺和缺血修饰白蛋白的评估。
Qatar Med J. 2025 Jun 11;2025(2):39. doi: 10.5339/qmj.2025.39. eCollection 2025.
6
Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease.胆碱代谢产物——氧化三甲胺对炎症性肠病免疫代谢的影响。
Front Immunol. 2025 Jul 17;16:1591151. doi: 10.3389/fimmu.2025.1591151. eCollection 2025.
7
Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular disease.新兴的治疗靶点,用于调节在心血管疾病中明显的微生物群介导的效应。
Front Cardiovasc Med. 2025 Jul 16;12:1631841. doi: 10.3389/fcvm.2025.1631841. eCollection 2025.
8
Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions.慢性肾脏病中的肠道微生物群重塑:肾脏替代疗法和治疗干预的影响
Front Med (Lausanne). 2025 Jul 15;12:1620247. doi: 10.3389/fmed.2025.1620247. eCollection 2025.
9
Fecal microbiota transplantation is a promising therapy for kidney diseases.粪便微生物群移植是一种很有前景的肾脏疾病治疗方法。
Front Med (Lausanne). 2025 Jul 9;12:1628722. doi: 10.3389/fmed.2025.1628722. eCollection 2025.
10
The Role of Microbiota in the Pathogenesis of Bullous Pemphigoid and Pemphigus Vulgaris: Evidence, Controversies, and Perspectives.微生物群在大疱性类天疱疮和寻常型天疱疮发病机制中的作用:证据、争议与展望
Int J Mol Sci. 2025 Jun 24;26(13):6076. doi: 10.3390/ijms26136076.
三甲胺 N-氧化物,一种依赖于肠道微生物群的代谢物,与患有心血管疾病的老年衰弱患者相关。
Clin Interv Aging. 2020 Sep 30;15:1809-1820. doi: 10.2147/CIA.S270887. eCollection 2020.
4
A simple liquid chromatography/differential ion mobility spectrometry tandem mass spectrometry method for the determination of trimethylamine-N-oxide in human serum: An application in dialysis patients.一种用于测定人血清中氧化三甲胺的简单液相色谱/差分离子淌度谱串联质谱法:在透析患者中的应用
Rapid Commun Mass Spectrom. 2021 Jan 15;35(1):e8965. doi: 10.1002/rcm.8965.
5
TMAO: how gut microbiota contributes to heart failure.氧化三甲胺:肠道微生物群如何导致心力衰竭。
Transl Res. 2021 Feb;228:109-125. doi: 10.1016/j.trsl.2020.08.007. Epub 2020 Aug 22.
6
Diet-related gut microbial metabolites and sensing in hypertension.与饮食相关的肠道微生物代谢物及其在高血压中的感知作用。
J Hum Hypertens. 2021 Feb;35(2):162-169. doi: 10.1038/s41371-020-0388-3. Epub 2020 Jul 30.
7
Trimethylamine N-Oxide in Relation to Cardiometabolic Health-Cause or Effect?三甲基胺 N-氧化物与心脏代谢健康的关系——是原因还是结果?
Nutrients. 2020 May 7;12(5):1330. doi: 10.3390/nu12051330.
8
Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine -Oxide (TMAO) by Liquid Chromatography-Mass Spectrometry.采用液相色谱-质谱法同时测定尿中的三甲基胺(TMA)和氧化三甲胺(TMAO)
Molecules. 2020 Apr 17;25(8):1862. doi: 10.3390/molecules25081862.
9
Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days.氧化三甲胺在缺血性中风后急性期升高,并在最初几天内下降。
Eur J Neurol. 2020 Aug;27(8):1596-1603. doi: 10.1111/ene.14253. Epub 2020 May 13.
10
Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort.采用 LC-MS/MS 法测定三甲基胺 N-氧化物(TMAO):基于人群的 PopGen 队列中的分布和相关性。
Clin Chem Lab Med. 2020 Apr 28;58(5):733-740. doi: 10.1515/cclm-2019-1146.